Chey Loveday
Institute of Cancer Research(GB)GGG (France)(FR)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Testicular diseases and treatments, Cancer Genomics and Diagnostics, BRCA gene mutations in cancer, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Most-Cited Works
- → Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic(2020)540 cited
- → Germline mutations in RAD51D confer susceptibility to ovarian cancer(2011)531 cited
- → Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study(2020)495 cited
- → The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated Infections(2001)355 cited
- → Genetic predisposition to mosaic Y chromosome loss in blood(2019)333 cited
- → Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer(2012)257 cited
- → Germline RAD51C mutations confer susceptibility to ovarian cancer(2012)251 cited
- → Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group(2019)233 cited
- → Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability(2017)209 cited
- → Disease evolution and outcomes in familial AML with germline CEBPA mutations(2015)193 cited